ArabFinance:  Kahira Pharmaceuticals and Chemical Industries Company (CPCI) reported a 31.6% Year on Year rise in its net profit in the first three months of the fiscal year (FY) 2019/2020, according to the company’s November 4^th financial statements filed to the Egyptian Exchange.

Net profit after tax stood at EGP 33.859 million in the July-September period of 2020, compared to EGP 25.733 million achieved in the prior-year period.

The company will distribute a cash dividend of EGP 3.20 per share on November 4^th for fiscal year FY 2019/2020.

Kahira Pharmaceuticals is an Egypt-based company involved in the manufacture and trade of pharmaceutical products for human and veterinary use.